MicroRNAs (miRNAs) are a class of highly abundant non-coding RNA molecules that are
involved in several biological processes. Many miRNAs are often deregulated in several …

Abstract MicroRNAs (miRNAs) are 20–22 nucleotides long small non-coding RNAs that
regulate gene expression post-transcriptionally. Last decade has witnessed emerging …

The approval of the first small interfering RNA (siRNA) drug Patisiran by FDA in 2018 marks
a new era of RNA interference (RNAi) therapeutics. MicroRNAs (miRNA), an important post …

The discovery of the first microRNA (miRNA) over 20 years ago has ushered in a new era in
molecular biology. There are now over 2000 miRNAs that have been discovered in humans …

Small noncoding RNAs, as post-translational regulators of many target genes, are not only
markers of neoplastic disease initiation and progression, but also markers of response to …

RNA interference (RNAi) provides researchers with a versatile means to modulate target
gene expression. The major forms of RNAi molecules, genome-derived microRNAs …

MicroRNAs (miRNAs) provide new therapeutic targets for many diseases, while their myriad
roles in development and cellular processes make them fascinating to study. We still do not …

MicroRNAs (miRNAs) are a class of short non-coding RNA molecules that are involved in
development and diseases. Early studies are focusing on the miRNA profile as a biomarker …

MicroRNAs (miRNAs) are attracting a growing interest in the scientific community due to
their central role in the etiology of major diseases. On the other hand, nanoparticle carriers …

Despite substantial progress in understanding the cancer-signaling network, effective
therapies remain scarce due to insufficient disruption of oncogenic pathways, drug …